EP2488192
COMBINATIONS OF A SPECIFIC HCV NS5A INHIBITOR AND AN HCV NS3 PROTEASE INHIBITOR
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
8.10.2010EP published:
30.8.2017EP application number:
10765917.9
EPO information:
European Patent Register
Max expiry date:
7.10.2030
Title:
COMBINATIONS OF A SPECIFIC HCV NS5A INHIBITOR AND AN HCV NS3 PROTEASE INHIBITOR
Timeline
Today
8.10.2010EP application
30.8.2017EP Publication
Owner
Name:
Bristol-Myers Squibb Holdings IrelandAddress:
Hinterbergstrasse 16, 6312, Steinhausen, CH
Inventor
Name:
LEMM, Julie A.Address:
Wallingford, Connecticut, US
Name:
VOSS, Stacey A.Address:
Wallingford, Connecticut, US
Name:
GAO, MinAddress:
Wallingford, Connecticut, US
Name:
CHANIEWSKI, Susan E.Address:
Wallingford, Connecticut, US
Name:
SHEAFFER, Amy K.Address:
Wallingford, Connecticut, US
Name:
MCPHEE, FionaAddress:
Wallingford, Connecticut, US
Priority
Number:
250648 PDate:
12.10.2009Country:
US
Number:
899840Date:
7.10.2010Country:
US
Classification
Categories:
A61K 38/06, A61K 45/06, A61K 31/4178, A61P 31/12